1. Home
  2. RCG vs SER Comparison

RCG vs SER Comparison

Compare RCG & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RCG

RENN Fund Inc

HOLD

Current Price

$2.76

Market Cap

18.1M

Sector

Finance

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.83

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCG
SER
Founded
N/A
2017
Country
United States
United States
Employees
N/A
13
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
19.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
RCG
SER
Price
$2.76
$1.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
7.2K
86.1K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$1.22
52 Week High
$3.31
$7.92

Technical Indicators

Market Signals
Indicator
RCG
SER
Relative Strength Index (RSI) 39.63 44.65
Support Level $2.48 $1.73
Resistance Level $3.00 $1.86
Average True Range (ATR) 0.06 0.11
MACD -0.01 -0.01
Stochastic Oscillator 27.15 22.09

Price Performance

Historical Comparison
RCG
SER

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: